loading

Greenwich Lifesciences Inc Azioni (GLSI) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
3.18%
4.1746
4.046 3.2823 8.0842 2.7291
Operating Income/Loss
3.18%
-4.1746
-4.046 -3.2823 -8.0842 -2.7291
Income/Loss From Continuing Operations Before Tax
3.14%
-4.1518
-4.0253 -3.2584 -8.0402 -2.6687
Income/Loss From Continuing Operations After Tax
3.14%
-4.1518
-4.0253 -3.2584 -8.0402 -2.6687
Net Income/Loss
3.14%
-4.1518
-4.0253 -3.2584 -8.0402 -2.6687
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2.02%
13.64
13.37 13.17 0.0445 13.14
Diluted Average Shares
2.02%
13.64
13.37 13.17 0.0445 13.14
Basic Earnings Per Share
0.00%
-0.30
-0.30 -0.25 -0.61 -0.20
Diluted Earnings Per Share
0.00%
-0.30
-0.30 -0.25 -0.61 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):